You sound quite emotional. Sure seeing the SP drop like that is nerve wracking for the stock holders but...it’s not like entirely surprising. I’ve been following the company for 5 months now and during this time I’ve seen/read enough to know all the risks that come with it, and there’s no shortage of those. Small company, OTC, potentially very strong drug, peculiar leadership...I mean, we should be expecting such things (like AF articles, WSJ articles, papers not getting published in time etc).
I think you might be overestimating the impact that this board has on the SP, however.